4.8 Article

Bio-inspired adhesive porous particles with human MSCs encapsulation for systemic lupus erythematosus treatment

Journal

BIOACTIVE MATERIALS
Volume 6, Issue 1, Pages 84-90

Publisher

KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2020.07.018

Keywords

Microfluidics; Mesenchymal stem cell; Hydrogel; Systemic lupus erythematosus; Particle

Funding

  1. Key Program of National Natural Science Foundation of China [81930043]
  2. Major International (Regional) Joint Research Project of China [81720108020]
  3. China Postdoctoral Science Foundation [2019M661809]

Ask authors/readers for more resources

The study introduces novel adhesive porous particles encapsulating human MSCs for SLE treatment, inspired by the natural microstructure of the sand tower worm nest. These porous microparticles protect MSCs from immune cells, maintain their functions, and facilitate nutrient exchange. The particles have the potential for chronic SLE treatment and other biomedical applications, showing increased cellular half-life and anti-inflammatory effects in vivo.
Mesenchymal stem cells (MSCs) therapy is a promising treatment for Systemic lupus erythematosus (SLE) patients. However, this method is encumbered by suboptimal phenotype of MSCs used in clinical settings, and a short in vivo persistence time. Herein, inspired by the natural microstructure of the sand tower worm nest, we proposed novel adhesive porous particles with human MSCs encapsulation via microfluidic electrospray technology for SLE treatment. The porous microparticles were formed by immediate gelation reaction between sodium alginate (ALG) and poly-D-lysine (PDL), and then sacrificed polyethylene oxide (PEO) to form the pores. The resultant microparticles could protect MSCs from immune cells while maintain their immune modulating functions, and achieve rapid exchange of nutrients from the body. In addition, owing to the electrostatic adsorption and covalent bonding between PDL and tissues, the porous microparticles could adhere to the bowel surfaces tightly after intraperitoneal injection. Through in vivo imaging system (IVIS) methods and in vivo study, it was demonstrated that the MSCs-encapsulated porous adhesive microparticles could significantly increase the cellular half-life, turn activated inflammatory macrophages into an anti-inflammatory profile, and ameliorate disease progression in MRL/lpr mice. Thus, the MSCs-encapsulated porous microparticles showed distinctive functions in chronic SLE treatment, with additional potential to be used in a variety of biomedical applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available